41% profit surge masks tighter sustainability: can credit beat hold without agri stress?

The quarter looks like a clean beat — 41% profit growth, credit expansion a third above guidance, asset quality improving across the board. But the tension sits just beneath the surface: write-off recovery (₹125 Cr) and debt-waiver gains (₹30 Cr NIM benefit) account for a meaningful slice of the reported PAT. These are real credits to the quarter — executed with discipline — but both are time-bound. The real question is whether the bank can sustain 23% credit growth as agri-gold exposure expands amid El Niño risk, and whether government debt-waiver disbursal meets the 31-Mar-27 deadline.

Revenue grew a solid 20.7% YoY to ₹8,606 Cr, and the 41% PAT jump is partly amplified by recovery timing. Write-off recovery of ₹125 Cr contributed 2–3 basis points to NIM, and debt-waiver recovery added ₹30 Cr in NIM benefit (also 2–3 bps). These are genuine credits — the bank executed well on collections, and government debt-waiver timing worked in its favor. But the government-receivable portion is ₹2,750 Cr, of which only ₹1,200 Cr was collected by 30-Sep. The deadline for the remaining ₹1,550 Cr is 31-Mar-27; after that, this tailwind reverses. Stripping out these recoveries, organic PAT growth is ~32–35%, still strong but materially below the headline 41%.

Credit delivery accelerated: Q1 FY27 guided 18% domestic credit; Q2 delivered 23%, beating by 5 pp. Retail, MSME, and Agri each grew 20%+, with Agri jumping 34% YoY. Asset quality reinforced: Q1 flagged stress monitoring; Q2 shows GNPA down 47 bps, agri stress down 35 bps, SMA 1&2 improving across segments. NIM guidance reaffirmed, delivered +12 bps: Management guided healthy margins; reported 3.97%, up 12 bps YoY, supported by write-off recovery and disciplined cost management. Debt-waiver recovery tracking, contingent on government: Q2 shows ₹1,200 Cr collected of ₹2,750 Cr government-receivable by 30-Sep; deadline 31-Mar-27. Remaining ₹1,550 Cr dependent on state government disbursal pace.

BOM trades at ₹79.95, below the 20-day (₹80.49) and 50-day (₹81.83) moving averages, but above the 200-day (₹76.67). The stock has pulled back 15.4% from its all-time high and sits up 44% from its 52-week low — a recovery arc that signals the market priced in genuine earnings-growth, but recent weakness suggests institutional caution. FII ownership stands at 5.81% (up 0.26 pp QoQ); DII at 14.27% (up 0.35 pp) — modest pickup but FII levels remain low vs. 2.34% five quarters ago. Promoter stake stable at 73.60%. This doesn't read as a crowded trade, but it's not a consensus darling either.

The pullback from the all-time high is instructive. That peak priced in sustained credit-growth momentum and asset-quality turnaround — both of which this quarter delivers. Yet the stock has given back gains; the market is pricing in uncertainty about whether this beat is structural or a confluence of write-off recovery, debt-waiver timing, and a strong agri-lending cycle that may not persist. That skepticism is justified: the 23% credit growth beats guidance by 5 pp, but 2–3 of those points come from GIFT City IBU leverage, a temporary window. Organic domestic growth is 20%+, but that's the right baseline to track, not the headline 23%.